| Mrs Jessica Erin Buesing, FNP-BC | |
|
27790 W Highway 22 Ste 37, Barrington, IL 60010-2396 | |
| (847) 382-4406 | |
| (847) 382-7098 |
| Full Name | Mrs Jessica Erin Buesing |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 27790 W Highway 22 Ste 37, Barrington, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962050971 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 036065375 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Good Shepherd Hospital | Barrington, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
News Archive
Mitochondria, the tiny structures inside our cells that generate energy, may play a key role in autism spectrum disorders (ASD).
With the emergence of COVID-19 (coronavirus disease 2019), researchers have been closely investigating the complex interplay between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the human immune system, and COVID-19 disease severity.
Active surveillance, also referred to as watchful waiting, is a viable option for many men with low risk prostate cancer although the concept continues to cause distress and confusion. James L. Mohler, MD, of Roswell Park Cancer Institute and chair of the NCCN Guidelines Panel for Prostate Cancer, discussed the role of active surveillance as well as other treatment options recommended in the recently updated NCCN Guidelines™ for Prostate Cancer at the NCCN 15th Annual Conference.
Curis, Inc. announced today that its licensee Debiopharm S.A. has treated the first patient in a Phase I clinical trial for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305.
› Verified 1 days ago
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
Mitochondria, the tiny structures inside our cells that generate energy, may play a key role in autism spectrum disorders (ASD).
With the emergence of COVID-19 (coronavirus disease 2019), researchers have been closely investigating the complex interplay between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the human immune system, and COVID-19 disease severity.
Active surveillance, also referred to as watchful waiting, is a viable option for many men with low risk prostate cancer although the concept continues to cause distress and confusion. James L. Mohler, MD, of Roswell Park Cancer Institute and chair of the NCCN Guidelines Panel for Prostate Cancer, discussed the role of active surveillance as well as other treatment options recommended in the recently updated NCCN Guidelines™ for Prostate Cancer at the NCCN 15th Annual Conference.
Curis, Inc. announced today that its licensee Debiopharm S.A. has treated the first patient in a Phase I clinical trial for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jessica Erin Buesing, FNP-BC 27790 W Highway 22 Ste 37, Barrington, IL 60010-2396 Ph: (847) 382-4406 | Mrs Jessica Erin Buesing, FNP-BC 27790 W Highway 22 Ste 37, Barrington, IL 60010-2396 Ph: (847) 382-4406 |
News Archive
Mitochondria, the tiny structures inside our cells that generate energy, may play a key role in autism spectrum disorders (ASD).
With the emergence of COVID-19 (coronavirus disease 2019), researchers have been closely investigating the complex interplay between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the human immune system, and COVID-19 disease severity.
Active surveillance, also referred to as watchful waiting, is a viable option for many men with low risk prostate cancer although the concept continues to cause distress and confusion. James L. Mohler, MD, of Roswell Park Cancer Institute and chair of the NCCN Guidelines Panel for Prostate Cancer, discussed the role of active surveillance as well as other treatment options recommended in the recently updated NCCN Guidelines™ for Prostate Cancer at the NCCN 15th Annual Conference.
Curis, Inc. announced today that its licensee Debiopharm S.A. has treated the first patient in a Phase I clinical trial for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305.
› Verified 1 days ago
Dr. Robert John Pines, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 27401 West Highway 22, Ste 111, Barrington, IL 60010 Phone: 847-382-2320 Fax: 847-382-0837 | |
Dr. Thomas Anthony Digiulio, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 27790 W Highway 22, Barrington, IL 60010 Phone: 847-381-8181 Fax: 847-381-0604 | |
Dr. Vidhi Srivastava Gadson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 111 Lions Dr Ste 210, Barrington, IL 60010 Phone: 847-304-0044 Fax: 847-304-5885 | |
Dr. Maura Fitzpatrick, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 600 Hart Rd Ste 310, Barrington, IL 60010 Phone: 847-304-0044 | |
Dr. Richard C. Smith, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 27401 West Highway 22, Suite 111, Barrington, IL 60010 Phone: 847-382-2320 Fax: 847-382-0837 | |
Baqir Anwer Jakvani, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 450 W Highway 22, Barrington, IL 60010 Phone: 847-381-0123 | |
Randy Ray Zimmerman, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 27750 W Highway 22, Ste 120, Barrington, IL 60010 Phone: 847-277-0500 Fax: 847-277-0505 |